Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction of apoptosis by anti-psoriatic treatments
2005-000707-34Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of infliximab, etanercept, methotrexate, cyclosporine, hydroxyurea and 5 more in psoriasis, sponsored by Newcastle Hospitals NHS Foundation Trust. Started Feb 2006; status: completed.
02
Drugs
infliximabetanerceptmethotrexatecyclosporinehydroxyurea
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2005-000707-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000707-34.